glp 1 drugs india Why China's Oral GLP-1 Could Disrupt India's $1 Billion Weight-Loss Market India issues strict guidelines limiting

Description

And the wrong choice can cost you significantly, both in compensation and in years of your life spent waiting for resolution

Researchers can distinguish absorption-limited from clearance-limited kinetics, examine metabolite generation and activity, and assess variability introduced by gastrointestinal physiology

Contact your GP, trial coordinator, or a healthcare professional promptly but without the urgency of 999 if you experience: A widespread or rapidly spreading rash, particularly if accompanied by fever, joint pain, or malaise Blistering, peeling, or open sores on the skin, which may indicate a more serious dermatological reaction Persistent or worsening injection site reactions that do not resolve within a few days Skin changes accompanied by systemic symptoms such as fatigue, fever, or lymph node swelling Severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome or toxic epidermal necrolysis, are rare but serious drug-related skin conditions requiring emergency assessment

Generally, these include a body mass index (BMI) of 30 or higher, or a BMI of 27 with related health concerns like diabetes or heart conditions

Researchers have also been investigating how the drug, and other GLP-1 drugs, could be used to treat obesity-related comorbidities, like cardiovascular disease and heart failure